Wound dressings, medical adhesives and sealants, hemostatic agents.
The world’s authorities on acute wound care describe protocols demanding:
- Control of bleeding
- Prevention of infection
- Control of pain
- Promotion of healing
Currently, no single product category meets all these demands. Medical professionals and consumers are usually forced to compromise and carefully select from a mix of products to treat a significant wound.
Hemotech’s technology however a) can satisfy all these protocol requirements in a single product regardless of wound type or severity, b) is so simple and cost effective that it may be used by professionals and laypersons alike, and c) may be deployed without a healthcare infrastructure.
SOLUTION AND TECHNOLOGY
We shift the wound treatment paradigm with a novel Wet Tissue Sealant (WTS). Upon contact with blood, our proprietary liquid cures in seconds into a flexible film and seals the wound, immediately stopping the bleeding and providing protection. It then releases easily as the wound dries and heals.
Our products promise to re-energize the $20Bn+ wound care market by redefining the nature of a wound dressing and setting the scene for a wave of new treatments.. A wound care franchise with our technology can develop a portfolio of clearly superior products stretching across many categories.
Preparing for production and commercialization of a general-purpose dressing for abrasions, avulsions, lacerations, and incisions.
Brian Wadsworth, Founder/CEO
Seasoned startup executive and builder of new businesses
Ramin Eghbali, CBO
20+ years of expertise in pharmaceutical and biotech
Peter Friedman, PhD, CSO
Expert in polymer chemistry
Dr. Gary Vilke, CMO
Vice Chair of Clinical Operations & Professor of Emergency Medicine, UCSD Health
Dr. Theodore Chan, Founder
Professor and Chair of the Dept of Emergency Medicine, UCSD Health
Simon Westbrook, CFO
Expert in IPOs, offerings, M&A
Hemotech Woundcare LLC
San Diego, CA 92121